Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program

Vaccine
Angelique G S C JansenEelko Hak

Abstract

With a retrospective nationwide cohort study in the Netherlands over 1992-2003, using mortality and viral surveillance data, the aim was to assess by means of rate difference methods the influenza-associated mortality in the elderly before and after the introduction of a nationwide influenza vaccination program in 1996 (vaccination coverage raised from below 50 to 80%). The average annual influenza-associated mortality declined in the years before and after the introduction from 131 to 105 per 100,000 persons (relative risk 0.80). The decline was largest in the age group 65-69 years (relative risk 0.54) and less in those aged 75 years and older. Validation by Serfling-type regression analysis revealed similar results. In conclusion, routine influenza vaccination among Dutch elderly was associated with a significant decrease in influenza-associated mortality, notably in those aged 65-69 years.

References

Aug 1, 1995·The Journal of Infectious Diseases·A R FalseyR F Betts
Feb 7, 1998·American Journal of Public Health·L SimonsenL B Schonberger
Jul 4, 1998·The Journal of Infectious Diseases·L SimonsenK Fukuda
Sep 17, 1998·Archives of Internal Medicine·K L NicholT von Sternberg
Dec 8, 1998·The Journal of Infectious Diseases·L L HanL J Anderson
Jan 29, 2000·The New England Journal of Medicine·H S IzurietaK Fukuda
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eelko HakKristin L Nichol
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Apr 4, 2003·The New England Journal of Medicine·Kristin L NicholMarika Iwane
Sep 16, 2004·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Feb 16, 2005·Archives of Internal Medicine·Lone SimonsenMark A Miller
Nov 14, 2006·Vaccine·Chong-Shan WangPesus Chou
Aug 24, 2007·The European Respiratory Journal·A G S C JansenE Hak
Oct 5, 2007·The New England Journal of Medicine·Kristin L NicholEelko Hak
Oct 5, 2007·The New England Journal of Medicine·John D Treanor
May 23, 2008·Journal of Clinical Epidemiology·Angelique G S C JansenEelko Hak

❮ Previous
Next ❯

Citations

Dec 20, 2011·BMC Infectious Diseases·Jens NielsenKåre Mølbak
Dec 1, 2008·Expert Review of Respiratory Medicine·Gerrit A van Essen
Apr 8, 2009·Expert Review of Vaccines·Patricia R Blank, Thomas D Szucs
Dec 10, 2015·Influenza and Other Respiratory Viruses·Scott A McDonaldJacco Wallinga
Nov 9, 2010·Ageing Research Reviews·Janet E McElhaney
May 21, 2009·Influenza and Other Respiratory Viruses·Melanie SavilleAgnes Hoffenbach
Jun 17, 2011·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Christopher R CarpenterUNKNOWN Society for Academic Emergency Medicine (SAEM) Geriatric Task Force
Feb 12, 2014·Influenza and Other Respiratory Viruses·Kyle WidmerH Keipp Talbot
Aug 23, 2012·Journal of Clinical Epidemiology·Maarten J BijlsmaFanny Janssen
Oct 30, 2013·Human Vaccines & Immunotherapeutics·Gábor KovácsBérengère Macabeo
Feb 10, 2018·Human Vaccines & Immunotherapeutics·Stefano CapriDonatella Panatto
Jul 8, 2014·The Cochrane Database of Systematic Reviews·Roger E Thomas, Diane L Lorenzetti
Dec 13, 2017·Der Internist·H J HeppnerA Kwetkat
Jun 29, 2018·Zeitschrift für Gerontologie und Geriatrie·A KwetkatH J Heppner
May 31, 2018·The Cochrane Database of Systematic Reviews·Roger E Thomas, Diane L Lorenzetti
Nov 19, 2019·Frontiers in Pharmacology·Yang LiuBirong Dong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.